Now Available: The Future of Parenteral Nutrition
Posted on September 5, 2010 by admin
– In 2009, approximately 390,000 patients in the major markets of the US, EU and Canada used parenteral nutrition products, accounting for total product sales of $1.3b. Through 2014, the total number of parenteral nutrition users in will rise by 10.0% per year to 628,000 and sales will expand by 11.3% per year, reflecting only nominal annual price increases. Four manufacturers currently jockey for share in this closely held market: market leader Baxter, enteral and parenteral products suppliers Fresenius Kabi and B. Braun, and Hospira. Although the introduction of new parenteral solutions is infrequent, these four players are differentiating themselves through hardware improvements, expanded pediatric labeling, new product formats and enhanced systems and services for home use. This report investigates these market opportunities, as well as emerging product development trend such as combination products and products developed for specialized disease populations. In each region profiled ?US, Canada and EU ?it investigates near and long term opportunities as well as recent product launches. Finally, it summarizes these opportunities in the context of product development initiatives currently underway at the leading manufacturers.
This report investigates these market opportunities, as well as emerging product development trend such as combination products and products developed for specialized disease populations. In each region profiled – US, Canada and EU – it investigates near and long term opportunities as well as recent product launches. rbcn0013
Scope of this research
* Develop deeper insight into the size and growth of the US, Canadian and EU parenteral nutrition industry, as well as individual EU country markets.
* Understand key product development trends in the parenteral nutrition market and the R&D strategies of the major players.
* Identify short and long term market opportunities in each region.
* Anticipate future parenteral nutrition market needs in light of the drivers and restraints acting upon the market.
* Describes the major market drivers and restraints in the US, Canada and EU, with detail provided for Germany, France, UK, Italy, Spain & Poland
Research and analysis highlights
Growth will be driven by increasing usage as the populations in these regions continue to age and incidence of conditions associated with parenteral nutrition, such as cancer and gastrointestinal disease, rises.
The total US, Canadian and EU parenteral nutrition market reached $1.3b in 2009 and is growing by 11.3% per year to reach $2.3bn in 2014. In 2009, Baxter led the market with 29.5% share, followed by Fresenius Kabi with 28.7%, B. Braun Melsungen with 22.2% and Hospira with 16.9%.
Major near term opportunities for new products include improved hardware and accessories, and products developed for home use. Important new recent launches include the triple-chamber bag, which three of the top four manufacturers now offer.
Key reasons to purchase this research
* What are the regional differences between the parenteral markets in the US, Canada, Germany, France, UK, Italy, Spain and Poland?
* Which companies are current and future key players and what are the issues driving new product development?
* What is limiting greater parenteral nutrition usage and how are prescribing decisions made by clinicians?
* What emerging products could significantly impact parenteral nutrition sales & what new product initiatives are being pursued by the leading players?
* What will the size and growth of the global parenteral nutrition market be through 2014?
For more information or to purchase this report, go to:
– http://www.fastmr.com/prod/96339_the_future_of_parentera …
Partial Table of Contents:
Table of Contents
About the author 2
Disclaimer 2
Executive summary 9
Introduction 9
Parenteral nutrition in the US & Canada 10
Parenteral nutrition in the EU 11
Opportunities in parenteral nutrition 12
Chapter 1 Introduction 13
Summary 13
Introduction 14
Parenteral vs. enteral nutrition 14
Major disease populations for parenteral nutrition 17
Cancer patients 18
Parenteral nutrition for cancer patients 20
Gastrointestinal disease patients 22
Parenteral nutrition for GI disease patients 23
AIDS patients 24
Parenteral nutrition for AIDS patients 25
Environments for parenteral nutrition 26
Inpatient environments 26
Outpatient environments 26
Major types of parenteral nutrition & product ingredients 28
Central vs. peripheral parenteral nutrition 28
Parenteral vs. total parenteral nutrition (TPN) 30
Standardized vs. individualized formulas 30
Pediatric patients 31
Products and ingredients 31
Partial parenteral nutrition 32
Total parenteral nutrition 33
Opportunities to incorporate medications into products 33
Alternatives to parenteral nutrition 34
Market summary 36
Conclusion 41
Chapter 2 Parenteral nutrition in the US & Canada 42
Summary 42
Introduction 43
Regulation 43
Insurance reimbursement 43
User populations 49
Parenteral nutrition in the US 50
Key products and players 50
Sales and market share, 2009-2014 51
Sales by disease population 55
How clinicians select products 56
New product development 57
Opportunities 59
Near term (2010-2012) 59
Long term (2013-2014) 60
Parenteral nutrition in Canada 62
Key products and players 63
Sales and market share, 2009-2014 63
Sales by disease population 65
How clinicians select products 65
New product development 66
Opportunities 67
Near term (2010-2012) 67
Long term (2013-2014) 67
Conclusions 67
Chapter 3 Parenteral nutrition in the EU 68
Summary 68
Introduction 69
Regulation 69
Insurance Reimbursement 70
User populations 70
Parenteral nutrition in the EU 71
Key products and players 72
Sales and market share 80
Total sales 81
Germany 82
France 83
UK 85
Italy 86
Spain 87
Poland 89
Sales by disease population 90
Germany 91
France 91
Full Table of Contents is available at:
– http://www.fastmr.com/catalog/product.aspx?productid=963 …
About Business Insights
Business Insights appreciate the importance of accurate, up-to-date incisive market and company analysis and their aim therefore is to provide a single, off-the-shelf, objective source of data, analysis and market insight. Business Insights work in association with leading industry experts to produce a range of reports across a wide range of industry sectors. By working in association with so many experts they are able to provide clients with more incisive market analysis specific to the client’s industry sector. No other market analysis company provides such focused and trusted market analysis, across such a wide range of industry sectors. View more research from Business Insights at http://www.fastmr.com/catalog/publishers.aspx?pubid=1003
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world’s top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
# # #